Skip to search formSkip to main contentSkip to account menu

Sandostatin

Known as: Sandostatine 
National Institutes of Health

Related topics

Related topics

17 relations

Narrower (6)

3-Tyr-octreotideCPTA-D-Phe(1)-octreotideRC 121SDZ 413

Broader (7)

AntidiarrhealsAntineoplastic Agents, HormonalGastrointestinal AgentsOctreotide
Octreotide 10 MG Injection [Sandostatin]Octreotide 30 MG Injection [Sandostatin]SMS 201-995lanreotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience
Background : Somatostatin analogues are the best therapy for controlling the symptoms of malignant carcinoid syndrome. Octreotide… 
Highly Cited
1997
Highly Cited
1997
A refined model for the somatostatin pharmacophore: conformational analysis of lanthionine-sandostatin analogs.
We report the conformational analysis of a series of analogs of sandostatin (octreotide, D-Phe1-c[Cys2-Phe3-D-Trp4-Lys5-Thr6-Cys… 
1996
1996
Sandostatin labeled with 99mTc: in vitro stability, in vivo validity and comparison with 111In-DTPA-octreotide.
Sandostatin, a synthetic octapeptide analog of a native hormone somatostatin, was labeled with a commonly available, inexpensive… 
1996
1996
Modified method using a somatostatin analogue, octreotide acetate (Sandostatin) to assess in vivo insulin sensitivity.
In order to evaluate the steady state plasma glucose (SSPG) method by using a new somatostatin derivative, octreotide acetate… 
Review
1993
Review
1993
From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics.
Somatostatin (SRIF) and its octapeptide analogue, octreotide (Sandostatin), have a similar high affinity for specific receptors… 
1993
1993
Treatment of pancreatic ascites and external pancreatic fistulas with a long-acting somatostatin analogue (Sandostatin).
Prior to the advent of somatostatin conservative therapy for pancreatic fistulas, treatment included intravenous nutritional… 
1993
1993
Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin.
The mechanism and response to treatment of severe life-threatening hypoglycaemia (plasma glucose 1.15 +/- 0.73 mM/l [+/- SD]) was… 
1989
1989
Metabolic Effects of Long-Acting Somatostatin Analogue (Sandostatin) in Type I Diabetic Patients on Conventional Therapy
We evaluated the effectiveness of a more potent and longer-acting somatostatin analogue (SMS 201–995) as an adjunct to insulin… 
1989
1989
Antidiuretic effect of Sandostatin (SMS 201-995) in healthy volunteers.
Ten male healthy volunteers were studied in order to determine whether the synthetic somatostatin analogue Sandostatin (SMS 201… 
1988
1988
Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man.
1. Somatostatin analogues, such as SMS 201-995 (sandostatin), have been suggested as treatment for a variety of disease states… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)